Evidence-based·Last reviewed June 1, 2026·How we grade evidence

Inositol nicotinate

VitaminBest with a meal

A flush-free niacin form — but the lack of flushing comes from low bioavailability, and the best placebo-controlled trial shows it doesn't move lipids. Modest legacy evidence for Raynaud's vasospasm during winter; weak everywhere else.

Quick decision guide

May help most

Adults who wanted niacin but couldn't tolerate the flush from nicotinic acid AND don't actually need the cholesterol-lowering effect.

Common dosing range

500–2000 mg per day; trials for Raynaud's used 4 g/day.

When to expect effects

Lipid effect: probably none. Raynaud's symptoms: weeks during cold-weather use.

Watch out for

Doesn't deliver clinically meaningful niacin into the bloodstream — if you actually need niacin for lipids, use nicotinic acid or a prescription niacin formulation instead.

Evidence snapshot

Flush avoidance vs nicotinic acidModerate
Raynaud's symptom reductionEmerging
Cholesterol / LDL loweringLow
Intermittent claudicationLow

What is it

Inositol nicotinate is a plant-derived ingredient sold as a dietary supplement and used in traditional herbal use. Found on roughly 1,415 U.S. supplement labels.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You have primary Raynaud's disease, the cold months are coming, and your clinician suggested a low-risk trial of a vasodilator
You tried niacin (nicotinic acid) for lipids, couldn't tolerate the flush, and your doctor has explained that IHN is unlikely to do the same lipid work
You're already taking it and tolerating it without expecting a niacin effect

Probably skip if

You're picking it because you want niacin's well-documented lipid-lowering effects — IHN doesn't deliver them
You can take, or already tolerate, prescription extended-release niacin or immediate-release nicotinic acid
You're hoping for energy, brain, or anti-aging benefits — no evidence supports those
You have liver disease, gout, or active peptic ulcer (use any niacin form with caution)

Evidence at a glance

Avoiding niacin flush

Good Evidence
Effect
Near-complete avoidance of niacin flush at doses that would otherwise cause it
Best fit
Adults who tried regular niacin and couldn't tolerate the flush
Time
Immediate (no flush to wait through)

Raynaud's phenomenon (cold-induced vasospasm)

Limited Evidence
Effect
Fewer and shorter vasospasm episodes vs placebo over a winter; magnitude not precisely quantified
Best fit
Adults with primary Raynaud's disease who want a low-risk option during cold months
Time
Weeks (the trial was a winter season)

Cholesterol and lipid lowering

Mixed Evidence
Effect
Equivalent to placebo in the head-to-head trial; no clinically meaningful lipid change
Best fit
None — if you need niacin's lipid effects, use nicotinic acid or extended-release niacin
Time
Not established (no effect demonstrated)

Intermittent claudication (peripheral arterial pain on walking)

Mixed Evidence
Effect
Not reliably quantified in extractable trial data
Best fit
None as first-line; possible adjunct only under specialist guidance
Time
Not established

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Avoiding niacin flush

Supplement benefit
Good Evidence

Inositol hexanicotinate reliably avoids the flushing, itching, and warming sensation that comes with nicotinic acid. NIH ODS notes the lack of flush is the main feature distinguishing IHN from regular niacin. The trade-off is that this also explains the low bioavailabilityniacin reaches the bloodstream in much smaller amounts, which is exactly why no flush response occurs.

Effect size
Near-complete avoidance of niacin flush at doses that would otherwise cause it
Time to effect
Immediate (no flush to wait through)
Best fit
Adults who tried regular niacin and couldn't tolerate the flush
Less likely
Anyone hoping the absence of flush still comes with niacin's lipid effects

Bottom line: Real benefit on tolerability, but the absence of flush is also the absence of clinical effect.

Raynaud's phenomenon (cold-induced vasospasm)

Disease adjunct
Limited Evidence

A small 1988 double-blind RCT (Sunderland et al., 23 patients, 4 g/day Hexopal vs placebo during winter) found patients on IHN had 'demonstrably shorter and fewer attacks of vasospasm,' though serum biochemistry and rheology didn't differ between groups. The mechanism isn't clear. Evidence is from one trial in one cold-weather seasonnot strong, but worth considering when the alternatives are calcium channel blockers (better-evidenced but with more side effects).

Effect size
Fewer and shorter vasospasm episodes vs placebo over a winter; magnitude not precisely quantified
Time to effect
Weeks (the trial was a winter season)
Best fit
Adults with primary Raynaud's disease who want a low-risk option during cold months
Less likely
Secondary Raynaud's (associated with scleroderma, lupus, etc.) — those need disease-modifying treatment

Bottom line: One small old RCT supports a modest cold-season benefit. Reasonable to try if your doctor agrees; not a replacement for first-line therapy.

Cholesterol and lipid lowering

Supplement benefit
Mixed Evidence

The marketing premise of IHNthat it's 'niacin without the flush' — implies it should lower LDL and raise HDL like nicotinic acid does. The best modern placebo-controlled trial (Keenan 2013) directly tested this: 1500 mg/day of wax-matrix extended-release niacin produced significant lipid improvements (LDL18%, HDL +12%) over 6 weeks, while IHN at the same dose showed no significant improvement in lipids and 'no evidence of bioavailability,' performing no better than placebo. This is consistent with NIH ODS's note that IHN absorption is ~30% lower than free nicotinic acid.

Effect size
Equivalent to placebo in the head-to-head trial; no clinically meaningful lipid change
Time to effect
Not established (no effect demonstrated)
Best fit
None — if you need niacin's lipid effects, use nicotinic acid or extended-release niacin
Less likely
Anyone with established dyslipidemia who needs an actual lipid intervention

Bottom line: Don't use IHN to lower cholesterol — the best controlled trial shows it doesn't work and the modern bioavailability data explain why.

Evidence is mixed

A 2019 conference abstract (AHA Circulation) reported IHN raised HDL ~10% in 43 patients over 12 weeks, but it was unblinded and uncontrolled. The 2013 Keenan placebo-controlled trial is the higher-quality evidence and shows no effect.

Intermittent claudication (peripheral arterial pain on walking)

Mechanism only
Mixed Evidence

Inositol nicotinate was historically used as a peripheral vasodilator for claudication. A 1988 controlled trial (O'Hara, Br J Clin Pract) tested IHN in claudication but the abstract is not indexed and quantitative outcomes aren't extractable from the PubMed record. Modern guidelines for peripheral arterial disease emphasize supervised exercise, smoking cessation, cilostazol, and statin therapynone recommend IHN.

Effect size
Not reliably quantified in extractable trial data
Time to effect
Not established
Best fit
None as first-line; possible adjunct only under specialist guidance
Less likely
Anyone with PAD looking for an evidence-based therapy — choose exercise + cilostazol + statin

Bottom line: Historical use; not a substitute for modern PAD therapy.

How it works

Inositol nicotinate contains a mixture of plant compounds, and the exact mechanism behind any effects depends on the specific preparation, the part of the plant used, and how it is extracted. Concentrations of active constituents can vary substantially between products. Most botanical effects are studied as a whole-plant or extract effect rather than tied to a single isolated molecule. Without strong human trial data, claims about how Inositol nicotinate works should be treated cautiously.

How to take it

1. Typical dose
• Typical supplement range: 500–2000 mg/day (often split 2–3 times daily) • Raynaud's trial dose (Sunderland 1988): 4 g/day during winter • 'No-flush niacin' marketing doses are typically 500 mg per capsule
2. Higher studied dose
Up to 4 g/day for short courses (3–4 months) in older Raynaud's and claudication trials. No long-term safety data above 2 g/day.
3. Timing
With food to minimize stomach upset.
4. With food
With food.
5. Split dosing
Most trials split the daily dose into 2–3 doses across the day; this is also typical for the supplement formulations.
6. How long to try
Raynaud's: try through one winter season (8–12 weeks). If you're (incorrectly) using it for lipids, get a baseline + 12-week lipid panel — the data predict no change, and that's a sign to switch to nicotinic acid or another therapy.

What to track

Number and severity of Raynaud's attacks during cold weather (if that's why you're taking it)
Stomach upset or nausea (uncommon but possible)
Liver enzymes (ALT/AST) if used long-term or at high doses — any niacin form can stress the liver in rare cases
Lipid panel — if you bought IHN expecting cholesterol lowering, the panel after 12 weeks will tell you it isn't doing that

Bottom line: Set expectations: this is a flush-free niacin form that doesn't deliver niacin's lipid effects. Use it only if a specific use case (Raynaud's) justifies it.

4 commercial forms

Compare the main delivery options and what they’re best suited for.

Inositol hexanicotinate (IHN, 'no-flush niacin')

What you bought

Inositol esterified to six niacin molecules. Marketed as flush-free, which is truebut the low flush is because niacin is poorly liberated/absorbed. Has not shown lipid effects in placebo-controlled trials.

~30% lower niacin absorption than free nicotinic acid; minimal free-niacin levels in plasma.

Nicotinic acid (immediate-release niacin)

What works for lipids

The classic lipid-modifying form. Lowers LDL ~10-25%, raises HDL ~15-35% at gram-level doses. Causes flushingusually manageable with low-dose aspirin and titration. Prescription extended-release versions also exist.

Near-complete oral absorption; rapid plasma niacin rise.

Nicotinamide (niacinamide)

B3 without lipid effect

Amide form of niacin. Used to correct B3 deficiency and for certain dermatologic conditions (Nicotinamide Riboside is a related newer compound). Does NOT lower cholesteroldifferent mechanism than nicotinic acid. No flushing.

Well absorbed; doesn't activate the niacin receptor that drives flush or lipid effects.

Wax-matrix extended-release niacin (prescription)

Strongest lipid effect

Prescription formulation engineered to release nicotinic acid slowly, reducing flush while preserving the lipid effect. The 2013 Keenan trial showed this form produces LDL18% and HDL +12% over 6 weekswhat people hope IHN will do but doesn't.

Slow release; full niacin effect on lipids; requires medical supervision for liver monitoring.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

mild stomach upsetnausea (uncommon)

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Inositol nicotinate has not been studied in pregnancy. Pregnant adults should not exceed the niacin RDA (18 mg/day) from supplements without medical guidance. The IHN form has low bioavailability so absolute niacin exposure is modest, but there are no safety data specifically supporting its use during pregnancy.

Bottom line: Generally well-tolerated (low bioavailability makes side effects rare). Don't substitute for prescription niacin if your clinician has prescribed it for lipids.

Interactions

statins (atorvastatin, simvastatin, etc.)Moderate

Standard nicotinic acid combined with statins raises the risk of myopathy and rhabdomyolysis. Whether the low-bioavailability IHN carries the same risk is unclear, but precaution is reasonable — discuss with prescriber.

diabetes medications (insulin, oral hypoglycemics)Moderate

Niacin can raise blood glucose. Monitor glucose if you have diabetes and are taking IHN long-term.

blood pressure medicationsMinor

IHN is a vasodilator and could theoretically add to the blood-pressure-lowering effect of antihypertensives. Monitor for dizziness.

anticoagulants / antiplatelet drugsMinor

Niacin can mildly affect platelet function; combination with warfarin or aspirin warrants monitoring.

Protocols featuring Inositol nicotinate

Evidence-backed routines where Inositol nicotinate plays a role.

Food sources

Beef liver, pan-fried

Amount
3 oz (14.9 mg niacin)
%DV
93%

Chicken breast, roasted

Amount
3 oz (10.3 mg)
%DV
64%

Turkey breast, roasted

Amount
3 oz (10.0 mg)
%DV
63%

Salmon, sockeye, cooked

Amount
3 oz (8.6 mg)
%DV
54%

Tuna, light, canned in water

Amount
3 oz (8.6 mg)
%DV
54%

Pork tenderloin, roasted

Amount
3 oz (6.3 mg)
%DV
39%

Peanuts, dry-roasted

Amount
1 oz (4.2 mg)
%DV
26%

Brown rice, cooked

Amount
1 cup (5.2 mg)
%DV
33%

Enriched cereals (fortified)

Amount
1 serving (varies; check label)
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Clearly labeled 'inositol hexanicotinate' or 'inositol hexaniacinate' — not just 'no-flush niacin' (some 'no-flush' products are nicotinamide, which behaves differently)
500 mg per capsule is the typical dose; check the label for the elemental niacin equivalent if listed
Third-party tested (USP, NSF, ConsumerLab) — confirms identity and dose

Be skeptical of

'Niacin without the flush' implying equivalent cholesterol-lowering — placebo-controlled data show this is not true
'Boosts HDL' or 'lowers LDL' claims on IHN-specific products — the only placebo-controlled trial showed no effect
Combination 'cardiovascular support' formulas pairing IHN with policosanol, red yeast rice, etc. that hide weak ingredients behind better-evidenced ones
Cognitive enhancement, brain fog, or anti-aging claims — no clinical evidence
Mega-dose 'flush-free' products (>2000 mg per serving) marketed for general wellness

Frequently asked questions

What is Inositol nicotinate used for?

Inositol nicotinate is used traditionally for various supportive purposes. Human evidence for specific health claims is generally limited, so it is best treated as a complementary option rather than a treatment.

Is Inositol nicotinate safe?

Inositol nicotinate is generally well tolerated at typical doses, but quality varies between products. People who are pregnant, breastfeeding, taking prescription medications, or managing a medical condition should check with a healthcare provider first.

How long does it take to work?

Effects of botanical supplements often take several weeks of consistent use, if they appear at all. Reassess after 8-12 weeks of regular use.

References by claim

Cholesterol and lipid lowering

Keenan, 2013Journal of Clinical Lipidology (2013) link

Welsh & Ede, 1961PubMed (1961) link

Raynaud's phenomenon (cold-induced vasospasm)

Sunderland et al., 1988Clinical Rheumatology (1988) link

Intermittent claudication (peripheral arterial pain on walking)

O'Hara et al., 1988British Journal of Clinical Practice (1988) link

Avoiding niacin flush

NIH Office of Dietary SupplementsNiacin — Health Professional Fact Sheet (2024) link

Inositol nicotinate on WikipediaWikipedia (2024) link

Track Inositol nicotinate with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed Jun 1, 2026·Evidence current as of Jun 1, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.